Trial Profile
A Clinical Experience Programme to Collect Data on the Safety and Efficacy of NovoMix 30 in the Treatment of Patients With Type 2 Diabetes in Jordan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 05 Jun 2015 New trial record